Bessemer Group Inc Incyte Corp Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Incyte Corp stock. As of the latest transaction made, Bessemer Group Inc holds 48,358 shares of INCY stock, worth $3.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,358

Previous 1,060 4462.08%

Holding current value

$3.47 Million

Previous $64,000 4893.75%

% of portfolio

0.01%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$57.33 - $68.61 $2.71 Million - $3.25 Million	47,298 Added 4462.08%	48,358 $3.2 Million
Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $12,999 - $16,192	-254 Reduced 19.33%	1,060 $64,000
Q1 2024 May 13, 2024	BUY	$56.55 - $66.59 $19,905 - $23,439	352 Added 36.59%	1,314 $75,000
Q4 2023 Feb 09, 2024	SELL	$52.16 - $64.19 $42,249 - $51,993	-810 Reduced 45.71%	962 $60,000
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $79,664 - $90,917	1,379 Added 350.89%	1,772 $103,000
Q2 2023 Aug 10, 2023	SELL	$60.95 - $75.51 $48,881 - $60,559	-802 Reduced 67.11%	393 $24,000
Q1 2023 May 10, 2023	SELL	$70.23 - $86.01 $12,220 - $14,965	-174 Reduced 12.71%	1,195 $87,000
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $16,459 - $20,606	-245 Reduced 15.18%	1,369 $109,000
Q3 2022 Nov 09, 2022	BUY	$66.18 - $82.86 $26,074 - $32,646	394 Added 32.3%	1,614 $107,000
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $20,251 - $25,453	306 Added 33.48%	1,220 $93,000
Q1 2022 May 12, 2022	BUY	$66.02 - $79.71 $330 - $398	5 Added 0.55%	914 $72,000
Q4 2021 Jan 27, 2022	BUY	$63.34 - $74.11 $42,247 - $49,431	667 Added 275.62%	909 $67,000
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $16,961 - $20,752	-247 Reduced 50.51%	242 $16,000
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $159 - $175	2 Added 0.41%	489 $41,000
Q1 2021 May 13, 2021	BUY	$76.02 - $100.5 $4,257 - $5,628	56 Added 12.99%	487 $0
Q4 2020 Feb 09, 2021	BUY	$80.74 - $97.7 $19,054 - $23,057	236 Added 121.03%	431 $37,000
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $22,543 - $29,067	-265 Reduced 57.61%	195 $18,000
Q2 2020 Aug 05, 2020	BUY	$74.18 - $108.93 $24,331 - $35,729	328 Added 248.48%	460 $48,000
Q1 2020 Apr 30, 2020	BUY	$63.18 - $85.97 $6,191 - $8,425	98 Added 288.24%	132 $10,000
Q4 2019 Feb 04, 2020	SELL	$73.04 - $95.72 $39 Million - $51.1 Million	-534,360 Reduced 99.99%	34 $3,000
Q3 2019 Nov 07, 2019	SELL	$72.82 - $86.52 $2.19 Million - $2.6 Million	-30,096 Reduced 5.33%	534,394 $39.7 Million
Q2 2019 Jul 19, 2019	BUY	$73.52 - $88.7 $41.5 Million - $50 Million	564,002 Added 115574.18%	564,490 $48 Million
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $15,508 - $21,513	244 Added 100.0%	488 $42,000
Q3 2018 Nov 06, 2018	BUY	$61.75 - $74.23 $12,967 - $15,588	210 Added 617.65%	244 $17,000
Q2 2018 Jul 25, 2018	BUY	$60.85 - $83.98 $486 - $671	8 Added 30.77%	34 $2,000
Q1 2018 May 10, 2018	BUY	$83.06 - $100.98 $415 - $504	5 Added 23.81%	26 $2,000
Q4 2017 Jan 30, 2018	SELL	$93.56 - $116.6 $16,092 - $20,055	-172 Reduced 89.12%	21 $2,000
Q3 2017 Nov 03, 2017	BUY	$109.15 - $138.27 $21,065 - $26,686	193	193 $23,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Incyte Corp Transaction History